Product Name

  • Name

    Cefpodoxime

  • EINECS
  • CAS No. 80210-62-4
  • Article Data10
  • CAS DataBase
  • Density 1.785 g/cm3
  • Solubility
  • Melting Point 200-202 °C
  • Formula C15H17N5O6S2
  • Boiling Point
  • Molecular Weight 427.462
  • Flash Point
  • Transport Information
  • Appearance off-white solid
  • Safety 22-36/37-45
  • Risk Codes 42/43
  • Molecular Structure Molecular Structure of 80210-62-4 (Cefpodoxime)
  • Hazard Symbols Xn
  • Synonyms 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid,7-[[(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-,[6R-[6a,7b(Z)]]-;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-,(6R,7R)- (9CI);Cefpodoxime acid;R 3763;
  • PSA 209.98000
  • LogP 0.37080

Synthetic route

(Z)-S-benzo[d]thiazol-2-yl 2-(2-aminothiazol-4-yl)-2-(methoxyimino)ethanethioate
80756-85-0

(Z)-S-benzo[d]thiazol-2-yl 2-(2-aminothiazol-4-yl)-2-(methoxyimino)ethanethioate

(6R,7R)-7-amino-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
24701-69-7

(6R,7R)-7-amino-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

cefpodoxime
80210-62-4

cefpodoxime

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran at -5 - 5℃; for 2h;82.86%
With triethylamine In tetrahydrofuran at 0 - 5℃; for 2h;82.86%
Stage #1: (Z)-S-benzo[d]thiazol-2-yl 2-(2-aminothiazol-4-yl)-2-(methoxyimino)ethanethioate; (6R,7R)-7-amino-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid With triethylamine In methanol at 8 - 12℃;
Stage #2: With sulfuric acid In methanol; water at 0 - 20℃; pH=2.4 - 2.5; Product distribution / selectivity;
With triethylamine In methanol; water at 15 - 20℃;81 mg
sodium methylate
124-41-4

sodium methylate

2-(2-amino-4-thiazolyl)-2-(Z)-methoxyiminoacetyl chloride
75994-59-1

2-(2-amino-4-thiazolyl)-2-(Z)-methoxyiminoacetyl chloride

7-amino-3-chloromethyl-3-cephem-4-carboxylic acid

7-amino-3-chloromethyl-3-cephem-4-carboxylic acid

cefpodoxime
80210-62-4

cefpodoxime

Conditions
ConditionsYield
Stage #1: sodium methylate; 7-amino-3-chloromethyl-3-cephem-4-carboxylic acid With benzyltrihexylammonium chloride; potassium iodide In dimethyl sulfoxide at 15℃; for 8h;
Stage #2: 2-(2-amino-4-thiazolyl)-2-(Z)-methoxyiminoacetyl chloride In dimethyl sulfoxide at 10℃; for 4h; Temperature; Solvent; Reagent/catalyst;
82.2%
(6R,7R)-7-{2-(2-Amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-3-methoxymethyl-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid 2,2-dimethyl-propionyloxymethyl ester
82618-98-2

(6R,7R)-7-{2-(2-Amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-3-methoxymethyl-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid 2,2-dimethyl-propionyloxymethyl ester

A

(2R,6R,7R)-7-{2-(2-Amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-3-methoxymethyl-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-3-ene-2-carboxylic acid
126747-46-4

(2R,6R,7R)-7-{2-(2-Amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-3-methoxymethyl-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-3-ene-2-carboxylic acid

B

cefpodoxime
80210-62-4

cefpodoxime

C

(2R,6R,7R)-7-{2-(2-Amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-3-methoxymethyl-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-3-ene-2-carboxylic acid 2,2-dimethyl-propionyloxymethyl ester
126617-55-8

(2R,6R,7R)-7-{2-(2-Amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-3-methoxymethyl-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-3-ene-2-carboxylic acid 2,2-dimethyl-propionyloxymethyl ester

Conditions
ConditionsYield
With water In N,N-dimethyl-formamide at 37℃; Rate constant; phosphate buffer, var. pH, add of bovin serum albumin (as protein);
7-Aminocephalosporanic acid
957-68-6

7-Aminocephalosporanic acid

cefpodoxime
80210-62-4

cefpodoxime

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: methanesulfonic acid / 5 - 12 °C
2: triethylamine / water; methanol / 15 - 20 °C
View Scheme
Multi-step reaction with 2 steps
1: methyl bisulfate / N,N-dimethyl-formamide; methanol / 5 h / 0 - 20 °C
2: triethylamine / tetrahydrofuran / 2 h / 0 - 5 °C
View Scheme
(6R,7R)-7-amino-3-hydroxymethyl-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid
15690-38-7

(6R,7R)-7-amino-3-hydroxymethyl-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid

cefpodoxime
80210-62-4

cefpodoxime

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: methanesulfonic acid / acetonitrile / 5 - 40 °C
2: triethylamine / methanol; water / 15 - 20 °C
View Scheme
Multi-step reaction with 2 steps
1: methanesulfonic acid / 5 - 40 °C
2: triethylamine / methanol; water / 15 - 20 °C
View Scheme
Multi-step reaction with 2 steps
1: methanesulfonic acid / 5 - 40 °C
2: triethylamine / methanol; water / 15 - 20 °C
View Scheme
Multi-step reaction with 2 steps
1: methanesulfonic acid / 5 - 40 °C
2: triethylamine / methanol; water / 15 - 20 °C
View Scheme
Multi-step reaction with 2 steps
1.1: boron trifluoride diethyl etherate / acetonitrile / 0.92 h / -20 - 25 °C
1.2: 25 °C
2.1: triethylamine / dichloromethane / 5 - 25 °C / pH 8 - 9
View Scheme
(benzothiazol-2-yl)-2-(2-aminothiazol-4-yl)-Z-2-methoxyimino-thioacetate

(benzothiazol-2-yl)-2-(2-aminothiazol-4-yl)-Z-2-methoxyimino-thioacetate

(6R,7R)-7-amino-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
24701-69-7

(6R,7R)-7-amino-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

cefpodoxime
80210-62-4

cefpodoxime

Conditions
ConditionsYield
Stage #1: (benzothiazol-2-yl)-2-(2-aminothiazol-4-yl)-Z-2-methoxyimino-thioacetate; (6R,7R)-7-amino-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid With triethylamine In methanol; water at 15 - 20℃;
Stage #2: With sulfuric acid In methanol; water
2-(2-amino-1,3-thiazol-4-yl)-1-(1,3-benzothiazol-2-ylsulfanyl)-2-(methoxyimino)ethan-1-one
94088-75-2

2-(2-amino-1,3-thiazol-4-yl)-1-(1,3-benzothiazol-2-ylsulfanyl)-2-(methoxyimino)ethan-1-one

(6R,7R)-7-amino-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
24701-69-7

(6R,7R)-7-amino-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

cefpodoxime
80210-62-4

cefpodoxime

Conditions
ConditionsYield
With triethylamine In dichloromethane at 5 - 25℃; pH=8 - 9; Temperature;
cefotaxime
65872-41-5

cefotaxime

cefpodoxime
80210-62-4

cefpodoxime

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: N,N-dimethyl acetamide / 0.08 h
1.2: 1.5 h / -11 - 15 °C
2.1: triethylamine / methanol / 0.5 h / -30 - 0 °C
View Scheme
C13H13N3O5S2

C13H13N3O5S2

(6R,7R)-7-amino-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
24701-69-7

(6R,7R)-7-amino-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

cefpodoxime
80210-62-4

cefpodoxime

Conditions
ConditionsYield
With triethylamine In methanol at -30 - 0℃; for 0.5h; Solvent;
(Z)-S-benzo[d]thiazol-2-yl 2-(2-aminothiazol-4-yl)-2-(methoxyimino)ethanethioate
80756-85-0

(Z)-S-benzo[d]thiazol-2-yl 2-(2-aminothiazol-4-yl)-2-(methoxyimino)ethanethioate

(6R,7R)-7-amino-3-hydroxymethyl-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid
15690-38-7

(6R,7R)-7-amino-3-hydroxymethyl-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid

trimethyl orthoformate
149-73-5

trimethyl orthoformate

cefpodoxime
80210-62-4

cefpodoxime

Conditions
ConditionsYield
Stage #1: trimethyl orthoformate With boron trifluoride diethyl etherate In acetonitrile at -30℃; for 1.58333h;
Stage #2: (6R,7R)-7-amino-3-hydroxymethyl-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid In acetonitrile at 25℃; for 0.25h;
Stage #3: (Z)-S-benzo[d]thiazol-2-yl 2-(2-aminothiazol-4-yl)-2-(methoxyimino)ethanethioate With triethylamine In dichloromethane at 0℃; pH=8 - 9;
1-iodoethyl isopropyl carbonate
84089-73-6, 91508-00-8

1-iodoethyl isopropyl carbonate

cefpodoxime
80210-62-4

cefpodoxime

cefpodoxime proxetil
87239-81-4

cefpodoxime proxetil

Conditions
ConditionsYield
Stage #1: cefpodoxime With 1-butyl-3-methylimidazolium hydroxide; potassium carbonate In N,N-dimethyl-formamide at -18 - -15℃; for 0.333333h; Inert atmosphere;
Stage #2: 1-iodoethyl isopropyl carbonate In N,N-dimethyl-formamide for 0.5h; Reagent/catalyst; Temperature; Solvent; Inert atmosphere;
94.5%
Stage #1: cefpodoxime With sodium acetate In water; N,N-dimethyl-formamide at 25℃; for 0.5h;
Stage #2: 1-iodoethyl isopropyl carbonate In water; N,N-dimethyl-formamide at 3℃; for 2h;
73%
Stage #1: cefpodoxime With N,N,N',N'-tetramethylguanidine In ISOPROPYLAMIDE at -12 - -4℃; for 1h;
Stage #2: 1-iodoethyl isopropyl carbonate In ISOPROPYLAMIDE at -15 - -8℃; for 0.5 - 1.5h; Product distribution / selectivity;
1-iodoethyl isopropyl carbonate
84089-73-6, 91508-00-8

1-iodoethyl isopropyl carbonate

cefpodoxime
80210-62-4

cefpodoxime

A

cefpodoxime proxetil
87239-81-4

cefpodoxime proxetil

B

1-(isopropoxycabonyloxy) ethyl (6R, 7R) [7-[2-(2-AMINOTHIAZOL-4-YL)-2-METHOXYIMINO-] [ACETAMIDO]-3-(METHOXYMETHYL) 3-CEPHEM-4-CARBOXYLATE]

1-(isopropoxycabonyloxy) ethyl (6R, 7R) [7-[2-(2-AMINOTHIAZOL-4-YL)-2-METHOXYIMINO-] [ACETAMIDO]-3-(METHOXYMETHYL) 3-CEPHEM-4-CARBOXYLATE]

Conditions
ConditionsYield
With disodium hydrogenphosphate; sodium carbonate; 1,8-diazabicyclo[5.4.0]undec-7-ene In ISOPROPYLAMIDE at -10 - -5℃; for 2.16667h;A 80.5%
B 0.5%
1-iodoethyl isopropyl carbonate
84089-73-6, 91508-00-8

1-iodoethyl isopropyl carbonate

cefpodoxime
80210-62-4

cefpodoxime

A

(R)-1-(isopropoxycarbonyloxy)ethyl-(+)-(6R,7R)-7-[2-(2-amino-4-thiazolyl)-2-((Z)-methoxyimino)acetamido]-3-methoxymethyl-8-oxo-5-thia-1-azabicyclo[4,2,0]oct-2-en-2-carboxylate
112345-70-7

(R)-1-(isopropoxycarbonyloxy)ethyl-(+)-(6R,7R)-7-[2-(2-amino-4-thiazolyl)-2-((Z)-methoxyimino)acetamido]-3-methoxymethyl-8-oxo-5-thia-1-azabicyclo[4,2,0]oct-2-en-2-carboxylate

B

1-isopropoxycarbonyloxyethyl(6R,7R)-7-[2-(2-aminothiazol-4-yl)-2(Z)-(methoxyimino)acetamido]-3-(methoxymethyl)-3-cephem-4-carboxylate

1-isopropoxycarbonyloxyethyl(6R,7R)-7-[2-(2-aminothiazol-4-yl)-2(Z)-(methoxyimino)acetamido]-3-(methoxymethyl)-3-cephem-4-carboxylate

Conditions
ConditionsYield
Stage #1: 1-iodoethyl isopropyl carbonate; cefpodoxime With 1,8-diazabicyclo[5.4.0]undec-7-ene In ISOPROPYLAMIDE; water at -15 - -6℃; for 0.5 - 0.75h;
Stage #2: With hydrogenchloride Product distribution / selectivity;
1-iodoethyl isopropyl carbonate
84089-73-6, 91508-00-8

1-iodoethyl isopropyl carbonate

cefpodoxime
80210-62-4

cefpodoxime

Reaxys ID: 12045429

Reaxys ID: 12045429

Conditions
ConditionsYield
Stage #1: cefpodoxime With 1,8-diazabicyclo[5.4.0]undec-7-ene In ISOPROPYLAMIDE at -10 - -6℃;
Stage #2: 1-iodoethyl isopropyl carbonate In ISOPROPYLAMIDE at -10 - -6℃; for 0.5 - 0.75h;
methanesulfonic acid
75-75-2

methanesulfonic acid

1-iodoethyl isopropyl carbonate
84089-73-6, 91508-00-8

1-iodoethyl isopropyl carbonate

cefpodoxime
80210-62-4

cefpodoxime

A

(R)-1-(isopropoxycarbonyloxy)ethyl-(+)-(6R,7R)-7-[2-(2-amino-4-thiazolyl)-2-((Z)-methoxyimino)acetamido]-3-methoxymethyl-8-oxo-5-thia-1-azabicyclo[4,2,0]oct-2-en-2-carboxylate
112345-70-7

(R)-1-(isopropoxycarbonyloxy)ethyl-(+)-(6R,7R)-7-[2-(2-amino-4-thiazolyl)-2-((Z)-methoxyimino)acetamido]-3-methoxymethyl-8-oxo-5-thia-1-azabicyclo[4,2,0]oct-2-en-2-carboxylate

B

1-isopropoxycarbonyloxyethyl(6R,7R)-7-[2-(2-aminothiazol-4-yl)-2(Z)-(methoxyimino)acetamido]-3-(methoxymethyl)-3-cephem-4-carboxylate

1-isopropoxycarbonyloxyethyl(6R,7R)-7-[2-(2-aminothiazol-4-yl)-2(Z)-(methoxyimino)acetamido]-3-(methoxymethyl)-3-cephem-4-carboxylate

Conditions
ConditionsYield
Stage #1: 1-iodoethyl isopropyl carbonate; cefpodoxime With 1,8-diazabicyclo[5.4.0]undec-7-ene In ISOPROPYLAMIDE at -15 - 6℃; for 0.666667h;
Stage #2: With hydrogenchloride
Stage #3: methanesulfonic acid With sodium hydrogencarbonate Product distribution / selectivity; more than 3 stages;
1-iodoethyl methyl carbonate

1-iodoethyl methyl carbonate

cefpodoxime
80210-62-4

cefpodoxime

1-(methoxycarbonyloxy)ethyl (6R,7R)-7-[(Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetamido]-3-(methoxymethyl)-3-cephem-4-carboxylate

1-(methoxycarbonyloxy)ethyl (6R,7R)-7-[(Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetamido]-3-(methoxymethyl)-3-cephem-4-carboxylate

Conditions
ConditionsYield
Stage #1: cefpodoxime With 1,8-diazabicyclo[5.4.0]undec-7-ene In N,N-dimethyl acetamide at 20℃; for 0.5h;
Stage #2: 1-iodoethyl methyl carbonate In N,N-dimethyl acetamide; toluene at -20 - -15℃; for 2.5h;
20.5 g
1-iodopropyl isopropyl carbonate

1-iodopropyl isopropyl carbonate

cefpodoxime
80210-62-4

cefpodoxime

1-(isopropoxycarbonyloxy)propyl (6R,7R)-7-[(Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetamido]-3-(methoxymethyl)-3-cephem-4-carboxylate

1-(isopropoxycarbonyloxy)propyl (6R,7R)-7-[(Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetamido]-3-(methoxymethyl)-3-cephem-4-carboxylate

Conditions
ConditionsYield
Stage #1: cefpodoxime With 1,8-diazabicyclo[5.4.0]undec-7-ene In N,N-dimethyl acetamide at 20℃; for 0.5h;
Stage #2: 1-iodopropyl isopropyl carbonate In N,N-dimethyl acetamide; toluene at -20 - -15℃; for 2.5h;
52 g
1-iodoethyl propyl carbonate
91507-81-2

1-iodoethyl propyl carbonate

cefpodoxime
80210-62-4

cefpodoxime

1-(propoxycarbonyloxy)ethyl (6R,7R)-7-[(Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetamido]-3-(methoxymethyl)-3-cephem-4-carboxylate

1-(propoxycarbonyloxy)ethyl (6R,7R)-7-[(Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetamido]-3-(methoxymethyl)-3-cephem-4-carboxylate

Conditions
ConditionsYield
Stage #1: cefpodoxime With 1,8-diazabicyclo[5.4.0]undec-7-ene In N,N-dimethyl acetamide at 20℃; for 0.5h;
Stage #2: 1-iodoethyl propyl carbonate In N,N-dimethyl acetamide; toluene at -20 - -15℃; for 2.5h;
20.5 g
cefpodoxime
80210-62-4

cefpodoxime

ethyl 1-iodoethylcarbonate
80196-04-9

ethyl 1-iodoethylcarbonate

1-(ethoxycarbonyloxy)ethyl (6R,7R)-7-[(Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetamido]-3-(methoxymethyl)-3-cephem-4-carboxylate

1-(ethoxycarbonyloxy)ethyl (6R,7R)-7-[(Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetamido]-3-(methoxymethyl)-3-cephem-4-carboxylate

Conditions
ConditionsYield
Stage #1: cefpodoxime With 1,8-diazabicyclo[5.4.0]undec-7-ene In N,N-dimethyl acetamide at 20℃; for 0.5h;
Stage #2: ethyl 1-iodoethylcarbonate In N,N-dimethyl acetamide; toluene at -20 - -15℃; for 2.5h;
20 g

Cefpodoxime Specification

The Cefpodoxime, with the CAS registry number 80210-62-4, is also known as 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid,7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-,(6R,7R)-. It belongs to the product categories of Various Metabolites and Impurities; Intermediates & Fine Chemicals; Metabolites & Impurities; Pharmaceuticals; Heterocycles; Sulfur & Selenium Compounds. This chemical's molecular formula is C15H17N5O6S2 and molecular weight is 427.46. What's more, its systematic name is (6R,7R)-7-{[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid. Cefpodoxime is an oral third generation cephalosporin antibiotic. It is marketed as the prodrug cefpodoxime proxetil by Pharmacia & Upjohn under the trade name Vantin. It is commonly used to treat acute otitis media, pharyngitis, and sinusitis. This chemical also finds use as oral continuation therapy when intravenous cephalosporins (such as ceftriaxone) are no longer necessary for continued treatment.

Physical properties of Cefpodoxime are: (1)ACD/LogP: 0.938; (2)# of Rule of 5 Violations: 1; (3)ACD/LogD (pH 5.5): -1.80; (4)ACD/LogD (pH 7.4): -2.81; (5)ACD/BCF (pH 5.5): 1.00; (6)ACD/BCF (pH 7.4): 1.00; (7)ACD/KOC (pH 5.5): 1.00; (8)ACD/KOC (pH 7.4): 1.00; (9)#H bond acceptors: 11; (10)#H bond donors: 4; (11)#Freely Rotating Bonds: 7; (12)Index of Refraction: 1.78; (13)Molar Refractivity: 100.498 cm3; (14)Molar Volume: 239.526 cm3 ; (15)Polarizability: 39.84 10-24cm3; (16)Surface Tension: 79.25 dyne/cm; (17)Density: 1.785 g/cm3

You can still convert the following datas into molecular structure:
(1)SMILES: O=C2N1/C(=C(\CS[C@@H]1[C@@H]2NC(=O)C(=N\OC)/c3nc(sc3)N)COC)C(=O)O
(2)Std. InChI: InChI=1S/C15H17N5O6S2/c1-25-3-6-4-27-13-9(12(22)20(13)10(6)14(23)24)18-11(21)8(19-26-2)7-5-28-15(16)17-7/h5,9,13H,3-4H2,1-2H3,(H2,16,17)(H,18,21)(H,23,24)/b19-8-/t9-,13-/m1/s1
(3)Std. InChIKey: WYUSVOMTXWRGEK-HBWVYFAYSA-N

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View